about
Field-caught permethrin-resistant Anopheles gambiae overexpress CYP6P3, a P450 that metabolises pyrethroidsInvolvement of the glycoproteic Ib-V-IX complex in nickel-induced platelet activation.Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patientsPersistent production of platelet thromboxane A2 in patients chronically treated with aspirinThe need for a consistent definition of "aspirin resistance"Aspirin resistance: is this term meaningful?gp91phox-dependent expression of platelet CD40 ligandAspirin resistanceNOX2 up-regulation is associated with artery dysfunction in patients with peripheral artery diseaseNew insights into the steen solution properties: breakthrough in antioxidant effects via NOX2 downregulationNOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease.Is NOX2 upregulation implicated in myocardial injury in patients with pneumonia?C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP.Epicatechin and catechin modulate endothelial activation induced by platelets of patients with peripheral artery disease.Hydrogen peroxide is involved in collagen-induced platelet activation.Platelets and oxygen radicals: mechanisms of functional modulation.An integrated genetic and physical map for the malaria vector Anopheles funestus.Dissecting the organ specificity of insecticide resistance candidate genes in Anopheles gambiae: known and novel candidate genes.Different degrees of NADPH oxidase 2 regulation and in vivo platelet activation: lesson from chronic granulomatous diseaseDark chocolate acutely improves walking autonomy in patients with peripheral artery disease.Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study.Platelet isoprostane overproduction in diabetic patients treated with aspirin.Vitamin E for the treatment of cardiovascular disease: is there a future?Similar Reduction of Cholesterol-Adjusted Vitamin E Serum Levels in Simple Steatosis and Non-Alcoholic Steatohepatitis.Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms.Relationship between platelet and urinary 8-Iso-PGF2α levels in subjects with different degrees of NOX2 regulationPatients with microvascular obstruction after primary percutaneous coronary intervention show a gp91phox (NOX2) mediated persistent oxidative stress after reperfusion.Aging-Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation.Role of NADPH oxidase in atherosclerosis.Vitamin E serum levels and bleeding risk in patients receiving oral anticoagulant therapy: a retrospective cohort studyModerate weight loss decreases oxidative stress and increases antioxidant status in patients with metabolic syndrome.Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty Liver.Total adiponectin is inversely associated with platelet activation and CHA₂DS₂-VASc score in anticoagulated patients with atrial fibrillation.Nutrition, supplements, and vitamins in platelet function and bleeding.Nutraceuticals in the early infancy.Effects of resveratrol and other wine polyphenols on vascular function: an update.Platelet oxidative stress and thrombosis.Statins as antithrombotic drugs.Statins as regulators of redox signaling in platelets.Is there a clinical role for oxidative stress biomarkers in atherosclerotic diseases?
P50
Q21092473-F00DA131-5334-40E1-B024-5BE6EC9CD7D0Q24811725-6D94F803-6F33-4FB6-8AFF-C7C321EF714DQ28167849-08BCAF65-AEA4-4149-9F1F-7C80D966D87BQ28193987-1CDE8D3E-90BB-4918-923A-387E09CA8CFFQ28199470-475D3527-B003-4BB0-9E23-5446713556FFQ28200018-1254DCD3-09E2-429D-9ED2-FCF2135795E0Q28208601-89914B75-5911-4030-AF37-B5D852D385B4Q28219485-7D67E9B8-772E-48AC-BCAF-B62A199AE413Q28259845-05385B6C-4006-4A8D-8367-5FD46230627DQ33562789-A9D21E0E-9896-4FA2-83B2-431192F284E5Q33583595-B202F82D-AFC8-459C-990E-70838B4BAF9EQ33687757-D33FDFDF-DB0D-41EB-A983-34D2261FA76CQ33812913-9726524F-D12E-4F7B-A590-202ACC95F952Q34080269-8B0CA2EE-6B5A-4DD7-8C96-191D64BCFF5BQ34452083-2F926AB6-37E5-4150-94E2-4097A66522EAQ34583599-25307F44-C39E-41A2-8146-DBDC9658FC13Q34586918-5CF9D65F-08CC-4626-816F-35FED67BC23CQ34636838-CDB50C8C-7F2F-4F24-90EC-1F5EFB2678E9Q35021974-CB5A13FE-107B-4F74-9292-FA1FA26AD815Q35026371-68F72B64-19D1-44AB-8F72-EA034A20D39FQ35640209-FC26CA33-8D53-483B-9AE3-97E18AA6D0AFQ35976574-4A4ACBF5-E25E-400F-8354-A19F115E7CCDQ36064433-35E5A567-084F-4860-84F8-5A53E3B1089CQ36751392-D3B82211-85A4-4993-96DC-780AFA863390Q36956791-D503CE4B-5195-4020-A61B-9DF3912E52CCQ36974316-D4E984F5-96DD-4CE6-8CD0-979D5912D0F3Q37291936-3C9D2A46-FEEE-4773-8743-7D5247201A72Q37364448-0277EC34-46DA-4D01-8F37-240C12A2EC52Q37445914-53452710-08EB-42B5-83E8-8CECBE2601A6Q37457754-B7090530-0486-44FB-B787-A5D0629E5468Q37556294-6FD88413-FCD9-4B7A-9BF8-A51F17AE33CAQ37616138-70653F39-0AB2-41C1-BFB8-A4F581631418Q37639726-4D032B9C-BCF1-4E61-A19F-6C8AEF5D8652Q37701160-A6DCEE3A-A7CC-4B80-B73D-B69516B6D4EBQ37765621-5AD87566-A82B-4BB9-AFE2-1AC316F5BF24Q37812765-9B069F02-C4D4-49A3-BCEF-816E2CEEF11DQ37972455-CE8E1393-525A-4B6D-AA52-929B1D447FA2Q38074147-C6C68545-F510-451B-90A5-002785E0EA16Q38132836-4DF971B9-121B-4D6A-BCD9-21266E6363B6Q38140700-C0470D1C-9105-46E5-B2D8-55ACE179C8C1
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Pasquale Pignatelli
@ast
Pasquale Pignatelli
@en
Pasquale Pignatelli
@es
Pasquale Pignatelli
@nl
type
label
Pasquale Pignatelli
@ast
Pasquale Pignatelli
@en
Pasquale Pignatelli
@es
Pasquale Pignatelli
@nl
prefLabel
Pasquale Pignatelli
@ast
Pasquale Pignatelli
@en
Pasquale Pignatelli
@es
Pasquale Pignatelli
@nl
P106
P1153
7003808847
P21
P31
P496
0000-0002-2265-7455